ctDNA may predict outcomes with first-line, but not second-line immunotherapy for melanoma
Bottom Line: Baseline levels of circulating tumor DNA (ctDNA) predicted responses to first-line, but not...
Bottom Line: Baseline levels of circulating tumor DNA (ctDNA) predicted responses to first-line, but not...